BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 12742638)

  • 21. Estrogen and progesterone dose-dependently reduce disruptive effects of restraint on lordosis behavior.
    White S; Uphouse L
    Horm Behav; 2004 Mar; 45(3):201-8. PubMed ID: 15047015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Attenuating effects of prior oestradiol benzoate priming on 5-HT-mediated lordosis behavior in rats are dose-dependent.
    Siddiqui A; Shaharyar S
    Acta Physiol Hung; 2007 Sep; 94(3):209-21. PubMed ID: 17853773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of the 5-HT1A agonist, 8-OH-DPAT, on sexual behaviors of the proestrous rat.
    Uphouse L; Montanez S; Richards-Hill R; Caldarola-Pastuszka M; Droge M
    Pharmacol Biochem Behav; 1991 Jul; 39(3):635-40. PubMed ID: 1838412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitory effects of the 5-HT1A agonists, 5-hydroxy- and 5-methoxy-(3-di-n-propylamino)chroman, on female lordosis behavior.
    Uphouse L; Caldarola-Pastuszka M; Moore N
    Neuropharmacology; 1993 Jul; 32(7):641-51. PubMed ID: 8361579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of lordosis in female hamsters and rats by 8-OH-DPAT treatment.
    Hebert TJ; Menard CS; Dohanich GP
    Physiol Behav; 1995 Mar; 57(3):523-7. PubMed ID: 7753891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Female sexual behavior following intracerebral infusion of the 5-HT1A agonist, 8-OH-DPAT, into the medial preoptic area.
    Uphouse L; Caldarola-Pastuszka M
    Brain Res; 1993 Jan; 601(1-2):203-8. PubMed ID: 8431766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estrogen reduces serotonin-1A receptor-mediated oxytocin release and Galpha(i/o/z) proteins in the hypothalamus of ovariectomized rats.
    D'Souza DN; Zhang Y; Damjanoska KJ; Carrasco GA; Sullivan NR; Garcia F; Battaglia G; Doncarlos LL; Muma NA; Van de Kar LD
    Neuroendocrinology; 2004; 80(1):31-41. PubMed ID: 15385710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of the behavioral effects of 8-OH-DPAT by estrogen and DOI.
    Maswood N; Uphouse L
    Pharmacol Biochem Behav; 1997 Dec; 58(4):859-66. PubMed ID: 9408187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of 5-HT1A-receptor agonist, 8-OH-DPAT, and GABAB-receptor agonist, baclofen, on lordosis in female rats with lesions in either the dorsal raphe nucleus or septum.
    Kishitake M; Yamanouchi K
    J Pharmacol Sci; 2005 Aug; 98(4):419-24. PubMed ID: 16079463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gender and estrous cycle effects of the 5-HT1A agonist, 8-OH-DPAT, on hypothalamic serotonin.
    Maswood S; Stewart G; Uphouse L
    Pharmacol Biochem Behav; 1995 Aug; 51(4):807-13. PubMed ID: 7545820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5-HT3 receptors in the ventromedial nucleus of the hypothalamus and female sexual behavior.
    Maswood N; Caldarola-Pastuszka M; Uphouse L
    Brain Res; 1997 Sep; 769(1):13-20. PubMed ID: 9374268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ovariectomy-induced increases in hypothalamic serotonin-1A receptor function in rats are prevented by estradiol.
    Raap DK; DonCarlos LL; Garcia F; Zhang Y; Muma NA; Battaglia G; Van de Kar LD
    Neuroendocrinology; 2002 Dec; 76(6):348-56. PubMed ID: 12566942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intracerebral actions of the 5-HT1A agonists, 8-OH-DPAT and buspirone and of the 5-HT1A partial agonist/antagonist, NAN-190, on female sexual behavior.
    Uphouse L; Caldarola-Pastuszka M; Montanez S
    Neuropharmacology; 1992 Oct; 31(10):969-81. PubMed ID: 1436391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic systemic administration of serotonergic ligands flibanserin and 8-OH-DPAT enhance HPA axis responses to restraint in female marmosets.
    Aubert Y; Bohl MA; Lange JR; Diol NR; Allers KA; Sommer B; Datson NA; Abbott DH
    Psychoneuroendocrinology; 2013 Jan; 38(1):145-54. PubMed ID: 22727480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of 5-HT(1A) receptors in fluoxetine-induced lordosis inhibition.
    Guptarak J; Sarkar J; Hiegel C; Uphouse L
    Horm Behav; 2010 Jul; 58(2):290-6. PubMed ID: 20223238
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estradiol modulation of the hyperphagia induced by the 5-HT1A agonist, 8-OH-DPAT.
    Salamanca S; Uphouse L
    Pharmacol Biochem Behav; 1992 Nov; 43(3):953-5. PubMed ID: 1448492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The 5HT(7) receptor subtype is involved in the regulation of female sexual behaviour in the rat.
    Siddiqui A; Niazi A; Shaharyar S; Wilson CA
    Pharmacol Biochem Behav; 2007; 87(3):386-92. PubMed ID: 17561239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A single pretreatment with 8-OH-DPAT reduces behavioral indices of serotonin 1A receptor activation in ovariectomized rats.
    Maswood N; Uphouse L
    Neuropharmacology; 1997; 36(11-12):1725-32. PubMed ID: 9517444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The 5-HT1A receptor agonist 8-hydroxy-2-di-n-(propylamino)tetralin (8-OH-DPAT) induces hyperglucagonemia in rats.
    Sugimoto Y; Kimura I; Watanabe Y; Yamada J
    Biol Pharm Bull; 2001 Oct; 24(10):1191-4. PubMed ID: 11642331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tropisetron increases the inhibitory effect of mild restraint on lordosis behavior of hormonally primed, ovariectomized rats.
    Uphouse L; Heckard D; Hiegel C; Guptarak J; Maswood S
    Behav Brain Res; 2011 Jun; 219(2):221-6. PubMed ID: 21238491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.